Cargando…

Levosimendan in Acute and Advanced Heart Failure: an Expert Perspective on Posology and Therapeutic Application

Levosimendan, a calcium sensitizer and potassium channel-opener, is widely appreciated by many specialist heart failure practitioners for its effects on systemic and pulmonary hemodynamics and for the relief of symptoms of acute heart failure. The drug’s impact on mortality in large randomized contr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bouchez, S., Fedele, F., Giannakoulas, G., Gustafsson, F., Harjola, V.-P., Karason, K., Kivikko, M., von Lewinski, D., Oliva, F., Papp, Z., Parissis, J., Pollesello, Piero, Pölzl, G., Tschöpe, C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267661/ https://www.ncbi.nlm.nih.gov/pubmed/30402660 http://dx.doi.org/10.1007/s10557-018-6838-2

Ejemplares similares

Levosimendan in Acute and Advanced Heart Failure: An Appraisal of the Clinical Database and Evaluation of Its Therapeutic Applications
por: Altenberger, Johann, et al.
Publicado: (2018)

Use of levosimendan in acute heart failure
por: Harjola, Veli-Pekka, et al.
Publicado: (2018)

Haemodynamic Balance in Acute and Advanced Heart Failure: An Expert Perspective on the Role of Levosimendan
por: Agostoni, Piergiuseppe, et al.
Publicado: (2019)

Repetitive levosimendan treatment in the management of advanced heart failure
por: Oliva, Fabrizio, et al.
Publicado: (2018)

Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use
por: Papp, Zoltán, et al.
Publicado: (2020)

Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use
por: Papp, Zoltán, et al.
Publicado: (2020)

Use of Levosimendan in Cardiac Surgery: An Update After the LEVO-CTS, CHEETAH, and LICORN Trials in the Light of Clinical Practice
por: Guarracino, Fabio, et al.
Publicado: (2018)

Renal Effects of Levosimendan: A Consensus Report
por: Yilmaz, Mehmet B., et al.
Publicado: (2013)

Levosimendan‐induced venodilation is mediated by opening of potassium channels
por: Burkhoff, Daniel, et al.
Publicado: (2021)

Levosimendan in Europe and China: An Appraisal of Evidence and Context
por: Kong, Xiangqing, et al.
Publicado: (2021)

Levosimendan: current data, clinical use and future development
por: Nieminen, M S, et al.
Publicado: (2013)

Use of Levosimendan in Patients with Advanced Heart Failure: An Update
por: Masarone, Daniele, et al.
Publicado: (2022)

The Posological Chart
Publicado: (1916)

Posological Tables
Publicado: (1878)

Repetitive levosimendan infusions for patients with advanced chronic heart failure in the vulnerable post‐discharge period
por: Pölzl, Gerhard, et al.
Publicado: (2018)

Pharmacological approaches to cardio-renal syndrome: a role for the inodilator levosimendan
por: Fedele, Francesco, et al.
Publicado: (2017)

Griffiths' Posological Tables
Publicado: (1874)

The Adenylate Cyclase Activator Forskolin Potentiates the Positive Inotropic Effect of the Phosphodiesterase Inhibitor Milrinone But Not of the Calcium Sensitizer Levosimendan nor of Its Hemodynamically Active Metabolites: An Apparent Conundrum
por: Levijoki, Jouko, et al.
Publicado: (2022)

Use of Levosimendan in Intensive Care Unit Settings: An Opinion Paper
por: Herpain, Antoine, et al.
Publicado: (2019)

Levosimendan in cardiac surgery
por: Harjola, V, et al.
Publicado: (2004)

Levosimendan in acute and advanced heart failure: still some chapters to be written
por: Pölzl, Gerhard
Publicado: (2018)

Rehospitalization after intermittent levosimendan treatment in advanced heart failure patients: a meta‐analysis of randomized trials
por: Silvetti, Simona, et al.
Publicado: (2017)

Short-Term Therapies for Treatment of Acute and Advanced Heart Failure—Why so Few Drugs Available in Clinical Use, Why Even Fewer in the Pipeline?
por: Pollesello, Piero, et al.
Publicado: (2019)

Interaction between renal function and the effect of levosimendan on long-term mortality of patients with low-output heart failure
por: Cleland, J, et al.
Publicado: (2003)

Posology and Serum-/Xeno-Free Engineered Adipose Stromal Cells Cell Sheets
por: Ochiai, Jun, et al.
Publicado: (2022)

The Posology of Dupilumab in Pediatric Patients With Atopic Dermatitis
por: Kamal, Mohamed A., et al.
Publicado: (2021)

Levosimendan in intensive care and emergency medicine: literature update and expert recommendations for optimal efficacy and safety
por: Girardis, M., et al.
Publicado: (2022)

Levosimendan Improves Oxidative Balance in Cardiogenic Shock/Low Cardiac Output Patients
por: Grossini, Elena, et al.
Publicado: (2020)

Study design of a mortality trial with intravenous levosimendan (the SURVIVE study) in patients with acutely decompensated heart failure
por: Mebazaa, A, et al.
Publicado: (2004)

Intravenous levosimendan vs. dobutamine in acute decompensated heart failure patients on beta-blockers
por: Bergh, Claes-Håkan, et al.
Publicado: (2010)

The inodilator levosimendan in repetitive doses in the treatment of advanced heart failure
por: Delgado, Juan F., et al.
Publicado: (2017)

Levosimendan Inhibits Peroxidation in Hepatocytes by Modulating Apoptosis/Autophagy Interplay
por: Grossini, Elena, et al.
Publicado: (2015)

Posology of insulins: A review of standard textbooks and product inserts
por: Bhutani, Garima, et al.
Publicado: (2015)

Inotropes and Inodilators for Acute Heart Failure: Sarcomere Active Drugs in Focus
por: Nagy, László, et al.
Publicado: (2014)

Differential effects of inotropes and inodilators on renal function in acute cardiac care
por: Zima, Endre, et al.
Publicado: (2020)

The inodilator levosimendan as a treatment for acute heart failure in various settings
por: Gustafsson, Finn, et al.
Publicado: (2017)

Levosimendan as a “Bridge to Optimization” in Patients with Advanced Heart Failure with Reduced Ejection—A Single-Center Study
por: Masarone, Daniele, et al.
Publicado: (2022)

Posological Considerations of Ocimum sanctum (Tulasi) as per Ayurvedic Science and Pharmaceutical Sciences
por: Narayana, D.B.A., et al.
Publicado: (2014)

Posological and Therapeutical Tables, Containing the Doses, Actions, and Uses of the Medicines in the British Pharmacopœia: With Poisons
Publicado: (1876)

Nivolumab exposure–response analysis for adjuvant treatment of melanoma supporting a change in posology
por: Sanghavi, Kinjal, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_88alfh4h2au5dg7u71gv8n7uav